【Labcorp、BioReference Healthのがん検査事業を最大2億2,500万ドルで正式取得】

✔ 取引総額：最大2億2,500万ドル（約335億円）
✔ 取得対象：がん検査サービス、顧客基盤、臨床検査資産
✔ OPKOはコア事業と前立腺がんリスク検査「4Kscore®」に集中

#Labcorp #BioReference #OPKOHealth #OncologyDiagnostics #PrecisionOncology #医療M&A #臨床検査 #がん診断 #4Kscore #医療DX

Labcorp Strengthens Oncology Services with BioReference Acquisition Labcorp has successfully acquired significant assets from BioReference Health, boosting its oncology testing services in the U.S., enhancing patient access.

Labcorp Strengthens Oncology Services with BioReference Acquisition #None #Labcorp #OPKO_Health #BioReference